{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04623541",
            "orgStudyIdInfo": {
                "id": "GCT3013-03"
            },
            "secondaryIdInfos": [
                {
                    "id": "2020-000848-57",
                    "type": "EUDRACT_NUMBER"
                },
                {
                    "id": "NL74221.056.20",
                    "type": "REGISTRY",
                    "domain": "CCMO"
                },
                {
                    "id": "MOH_2023-04-02_012496",
                    "type": "REGISTRY",
                    "domain": "MyTrial"
                },
                {
                    "id": "2023-504828-25-00",
                    "type": "CTIS"
                },
                {
                    "id": "1006575",
                    "type": "OTHER",
                    "domain": "IRAS ID; UK Research Summaries Database"
                }
            ],
            "organization": {
                "fullName": "Genmab",
                "class": "INDUSTRY"
            },
            "briefTitle": "Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome",
            "officialTitle": "A Phase 1b/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody\u00ae-CD3xCD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome",
            "acronym": "EPCORE\u2122 CLL-1",
            "therapeuticArea": [
                "Rare Diseases",
                "Oncology and Hematology"
            ],
            "study": "safety-and-efficacy-study-of-epcoritamab-in-subjects-with-relapsed-refractory-chronic-lymphocytic-leukemia-and-richter-s-syndrome"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": true,
                "nctId": "NCT05733650",
                "statusForNctId": "APPROVED_FOR_MARKETING"
            },
            "startDateStruct": {
                "date": "2020-11-25",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-10-27",
            "studyFirstSubmitQcDate": "2020-11-05",
            "studyFirstPostDateStruct": {
                "date": "2020-11-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Genmab",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "AbbVie",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The study is a global, multi-center safety and efficacy trial of epcoritamab, an antibody also known as EPKINLY\u2122 and GEN3013 (DuoBody\u00ae-CD3xCD20). Epcoritamab will either be studied as:\n\n* Monotherapy, or\n* Combination therapy:\n\n  * epcoritamab + venetoclax\n  * epcoritamab + lenalidomide\n  * epcoritamab + R-CHOP (i.e., rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine (Oncovin\u00ae) and prednisone).\n\nThe study includes patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL)/small lymphocytic lymphoma (SLL) and patients with Richter's Syndrome (RS).\n\nStudy participants with R/R CLL/SLL are treated either with epcoritamab as monotherapy or epcoritamab + venetoclax. Study participants with RS are treated either with epcoritamab as monotherapy or epcoritamab + lenalidomide or epcoritamab + R-CHOP. The trial consists of two parts, a dose-escalation phase (phase Ib) and an expansion phase (phase II). Patients with RS are only included in the expansion phase.\n\nEpcoritamab will be injected subcutaneously (under the skin). Standard-of-care and combination treatments (venetoclax, lenalidomide, and R-CHOP) will be given either orally (by mouth) or intravenously (in a vein).\n\nStudy details include:\n\n* Study duration will be up to 5 years.\n* The treatment duration for each participant will be between 18 months (1.5 years) and 24 months (2 years), depending upon the treatment arm assigned.\n* The visit frequency will be either weekly, every other week, or monthly, depending upon the part of the study.\n\nAll participants will receive active drug; no one will be given placebo.",
            "detailedDescription": "The purpose of the dose-escalation phase of the trial is to determine the recommended phase 2 dose (RP2D) and the maximum tolerated dose (MTD; if reached) as well as establish the safety profile of epcoritamab monotherapy and epcoritamab + venetoclax in participants with R/R CLL.\n\nThe purpose of the expansion phase is to assess and evaluate the preliminary efficacy, safety and tolerability profiles of epcoritamab monotherapy and epcoritamab + venetoclax at the RP2D for patients with R/R CLL/SLL. Along with this, epcoritamab monotherapy, epcoritamab + lenalidomide and epcoritamab + R-CHOP will be evaluated in patients with RS to assess their efficacy, safety and tolerability profiles."
        },
        "conditionsModule": {
            "conditions": [
                "Relapsed/Refractory Chronic Lymphocytic Leukemia",
                "Small Lymphocytic Lymphoma",
                "Richter's Syndrome"
            ],
            "keywords": [
                "DuoBody\u00ae",
                "Bispecific antibodies",
                "Anti-CD3",
                "Anti-CD20"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 184,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Epcoritamab in R/R CLL/SLL",
                    "type": "EXPERIMENTAL",
                    "description": "In both study phases. Participants in the expansion phase will be treated at the RP2D defined in the dose-escalation phase.",
                    "interventionNames": [
                        "Biological: Epcoritamab"
                    ]
                },
                {
                    "label": "Epcoritamab in RS",
                    "type": "EXPERIMENTAL",
                    "description": "Only in expansion phase.",
                    "interventionNames": [
                        "Biological: Epcoritamab"
                    ]
                },
                {
                    "label": "Epcoritamab + Venetoclax in R/R CLL/SLL",
                    "type": "EXPERIMENTAL",
                    "description": "In both study phases. Participants in the expansion phase will be treated at the RP2D defined in the dose-escalation phase.",
                    "interventionNames": [
                        "Biological: Epcoritamab",
                        "Drug: Venetoclax"
                    ]
                },
                {
                    "label": "Epcoritamab + Lenalidomide in RS",
                    "type": "EXPERIMENTAL",
                    "description": "Only in expansion phase.",
                    "interventionNames": [
                        "Biological: Epcoritamab",
                        "Drug: Lenalidomide"
                    ]
                },
                {
                    "label": "Epcoritamab + R-CHOP in RS",
                    "type": "EXPERIMENTAL",
                    "description": "Only in expansion phase.",
                    "interventionNames": [
                        "Biological: Epcoritamab",
                        "Drug: rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "Epcoritamab",
                    "description": "Epcoritamab will be administered subcutaneously in cycles of 28 days (except Cycle 1 for high-dose cohorts = 35 days).",
                    "armGroupLabels": [
                        "Epcoritamab + Venetoclax in R/R CLL/SLL",
                        "Epcoritamab in R/R CLL/SLL"
                    ],
                    "otherNames": [
                        "EPKINLY\u2122",
                        "GEN3013",
                        "DuoBody\u00ae-CD3xCD20"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Epcoritamab",
                    "description": "Epcoritamab will be administered subcutaneously in cycles of 21 days (Cycle 1-6) and 28 days for Cycle 7 and beyond.",
                    "armGroupLabels": [
                        "Epcoritamab + R-CHOP in RS"
                    ],
                    "otherNames": [
                        "EPKINLY\u2122",
                        "GEN3013",
                        "DuoBody\u00ae-CD3xCD20"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone",
                    "description": "R-CHOP will be administered intravenously in cycles of 21 days for the first 6 cycles.",
                    "armGroupLabels": [
                        "Epcoritamab + R-CHOP in RS"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Venetoclax",
                    "description": "Venetoclax tablets will be administered orally once daily during the 5-week ramp up period and during Cycle 1-26 of 28 or 35 days each.",
                    "armGroupLabels": [
                        "Epcoritamab + Venetoclax in R/R CLL/SLL"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Epcoritamab",
                    "description": "Epcoritamab will be administered subcutaneously in cycles of 28 days.",
                    "armGroupLabels": [
                        "Epcoritamab + Lenalidomide in RS",
                        "Epcoritamab in RS"
                    ],
                    "otherNames": [
                        "EPKINLY\u2122",
                        "GEN3013",
                        "DuoBody\u00ae-CD3xCD20"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Lenalidomide",
                    "description": "Lenalidomide capsules will be administered once daily for 21 days in each cycle of 28 days up to 12 cycles.",
                    "armGroupLabels": [
                        "Epcoritamab + Lenalidomide in RS"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Dose Escalation Phase (R/R CLL arm): Number of Participants with Dose Limiting Toxicities (DLTs)",
                    "description": "DLT events were defined as clinically significant adverse events (AEs) or abnormal laboratory values assessed as unrelated to disease progression, underlying disease, intercurrent illness, or concomitant medications as assessed per Common Terminology Criteria for Adverse Events (NCI-CTCAE) criteria version 5.0.",
                    "timeFrame": "During the first cycle for low dose cohorts (Cycle length = 28 days) and for high dose cohorts (Cycle length = 35 days)"
                },
                {
                    "measure": "Dose Escalation Phase: Number of Participants with Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)",
                    "timeFrame": "From first dose until the end of the safety follow-up period (60 days after last dose)"
                },
                {
                    "measure": "Dose Escalation Phase: Number of Participants with Cytokine Release Syndrome (CRS), Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) and Clinical Tumor Lysis Syndrome (CTLS)",
                    "description": "CRS and ICANS will be graded based on American Society for Transplantation and Cellular Therapy (ASTCT) criteria. CTLS will be graded according to Cairo-Bishop criteria.",
                    "timeFrame": "From first dose until the end of the safety follow-up period (60 days after last dose)"
                },
                {
                    "measure": "Expansion Phase: Overall Response Rate (ORR)",
                    "description": "ORR is defined as the percentage of participants who achieve a response of partial response or complete response, prior to initiation of subsequent therapy. R/R CLL participants will be assessed according to International Workshop on Chronic Lymphocytic Leukemia (iwCLL) criteria and the RS participants according to Lugano criteria.",
                    "timeFrame": "Up to 5 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Expansion Phase: Number of Participants with TEAEs and SAEs",
                    "timeFrame": "From first dose until the end of the safety follow-up period (60 days after last dose)"
                },
                {
                    "measure": "Dose Escalation Phase: ORR",
                    "description": "ORR is defined as percentage of participants who achieve a response of partial response or complete response, prior to initiation of subsequent therapy as assessed by iwCLL criteria.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Both Phases: Duration of Response (DOR)",
                    "description": "DOR is defined among responders, as the time from the initial documentation of response to the date of disease progression or death, whichever occurs earlier.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Both Phases: Number of Participants with Complete Remission (CR) / CR with Incomplete Bone Marrow Recovery (CRi)",
                    "description": "CR and CRi for R/R CLL participants will be assessed according to iwCLL criteria and CR for the RS participants, according to Lugano criteria.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Both Phases: Time to Response (TTR)",
                    "description": "TTR is defined among responders, as the time between first dose of epcoritamab and the initial documentation of response.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Both Phases: Progression Free Survival (PFS)",
                    "description": "PFS is defined as the time from the first dosing date of epcoritamab and the date of disease progression or death, whichever occurs earlier.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Both Phases: Overall Survival (OS)",
                    "description": "OS is defined as the time from the first dosing date of epcoritamab and the date of death due to any cause.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Both Phases: Time to Next Systemic Anti-cancer Therapy (TTNT)",
                    "description": "TTNT is defined as the time from the first dosing date of epcoritamab to the first documented administration of subsequent systemic anticancer therapy.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Both Phases: Area Under the Concentration-time Curve (AUC) From Time Zero to Last Quantifiable Sample (AUClast) in Epcoritamab",
                    "timeFrame": "Predose and post dose at multiple timepoints at end of each cycle for low dose and high dose cohorts (Cycle length = 28 days, except Cycle 1 for high dose cohorts = 35 Days)"
                },
                {
                    "measure": "Both Phases: AUC From Time Zero to Infinity (AUCinf) in Epcoritamab",
                    "timeFrame": "Predose and post dose at multiple timepoints at end of each cycle for low dose and high dose cohorts (Cycle length = 28 days, except Cycle 1 for high dose cohorts = 35 Days)"
                },
                {
                    "measure": "Both Phases: Maximum (Peak) Plasma Concentration (Cmax) in Epcoritamab",
                    "timeFrame": "Predose and post dose at multiple timepoints at end of each cycle for low dose and high dose cohorts (Cycle length = 28 days, except Cycle 1 for high dose cohorts = 35 Days)"
                },
                {
                    "measure": "Both Phases: Pre-dose (Trough) Concentrations (Cthrough) in Epcoritamab",
                    "timeFrame": "Predose and post dose at multiple timepoints at end of each cycle for low dose and high dose cohorts (Cycle length = 28 days, except Cycle 1 for high dose cohorts = 35 Days)"
                },
                {
                    "measure": "Both Phases: Time to Reach Cmax (Tmax) in Epcoritamab",
                    "timeFrame": "Predose and post dose at multiple timepoints at end of each cycle for low dose and high dose cohorts (Cycle length = 28 days, except Cycle 1 for high dose cohorts = 35 Days)"
                },
                {
                    "measure": "Both Phases: Elimination Half-life (T1/2) in Epcoritamab",
                    "timeFrame": "Predose and post dose at multiple timepoints at end of each cycle for low dose and high dose cohorts (Cycle length = 28 days, except Cycle 1 for high dose cohorts = 35 Days)"
                },
                {
                    "measure": "Both Phases: Total Body Clearance of Drug From Plasma (CL) in Epcoritamab",
                    "timeFrame": "Predose and post dose at multiple timepoints at end of each cycle for low dose and high dose cohorts (Cycle length = 28 days, except Cycle 1 for high dose cohorts = 35 Days)"
                },
                {
                    "measure": "Both Phases: Volume of distribution (Vd) in Epcoritamab",
                    "timeFrame": "Predose and post dose at multiple timepoints at end of each cycle for low dose and high dose cohorts (Cycle length = 28 days, except Cycle 1 for high dose cohorts = 35 Days)"
                },
                {
                    "measure": "Both Phases: Lymphoid Cells for Immunophenotyping",
                    "description": "Evaluation of B cells, T cells and their activation",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Expansion Phase: Number of Participants with CRS, ICANS and CTLS",
                    "description": "CRS and ICANS will be graded based on ASTCT criteria. CTLS will be graded according to Cairo-Bishop criteria.",
                    "timeFrame": "From first dose until the end of the safety follow-up period (60 days after last dose)"
                },
                {
                    "measure": "Expansion Phase: Percentage of Participants with Minimal Residual Disease (MRD) Negativity",
                    "description": "MRD negativity rate, is defined as the proportion of participants with at least 1 undetectable MRD result according to the specific threshold, prior to initiation of subsequent therapy.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Both Phases: Number of Participants with Anti-drug Antibodies (ADA) to Epcoritamab",
                    "timeFrame": "Up to end of treatment period (Up to 2 years)"
                },
                {
                    "measure": "Expansion Phase: Number of Participants with Partial Remission (PR)/Nodular Partial Remission (nPR)",
                    "description": "nPR is defined as PR with residual nodules or suspicious lymphocytic infiltrates in participants who are in remission. nPR is only calculated for R/R CLL.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Both Phases: Duration of MRD Negativity",
                    "description": "The time from first achieving MRD negativity after start of treatment to the MRD conversion to positive.",
                    "timeFrame": "Up to 5 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria\n\n1. Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1 or 2.\n2. Evidence of CD20 positivity in a sample representative of the disease at Screening.\n3. Acceptable hematology parameters and organ function based on baseline bloodwork.\n4. For R/R CLL arms - Must have active CLL/SLL disease requiring treatment per iwCLL 2018 criteria.\n5. For R/R CLL arms - Received at least 2 prior lines of systemic anti-neoplastic therapy including a Bruton's tyrosine kinase (BTK) inhibitor.\n6. For all RS arms - Have tumor biopsy-proven CD20+ Diffuse large B-cell Lymphoma (DLBCL) and a clinical history of CLL/SLL.\n7. For all RS arms - Must have measurable disease by fluorodeoxyglucose-positron emission tomography (FDG-PET) and computed tomography (CT) or magnetic resonance imaging (MRI) scan.\n8. For all RS arms - Must provide mandatory formalin-fixed, paraffin-embedded (FFPE) tumor biopsy sample.\n9. Life expectancy \\>3 months on standard of care (SOC).\n10. For RS - monotherapy arm: Deemed as ineligible for chemoimmunotherapy at investigator's discretion or participant who refuses to receive intensive chemotherapy\n11. For RS - lenalidomide combination therapy arm\n\n    * Deemed as ineligible for chemoimmunotherapy at the investigator's discretion, or participant who refuses to receive intensive chemotherapy.\n    * Eligible for treatment with lenalidomide.\n    * Must be willing to use contraception and adhere to the Lenalidomide Pregnancy Risk Minimization Plan\n12. For RS - R-CHOP combination Therapy Arm -\n\n    * Eligible for treatment with R-CHOP.\n13. For R/R CLL - venetoclax combination Therapy arm - after receiving at least 1 prior line of systemic antineoplastic therapy.\n\nKey Exclusion Criteria\n\n1. Received prior treatment with a CD3\u00d7CD20 bispecific antibody.\n2. Received any prior allogeneic hematopoietic stem cell transplantation (HSCT) or solid organ transplantation.\n3. Received (CAR) T-cell therapy within 100 days or an investigational drug within 4 weeks, prior to first dose of epcoritamab.\n4. Autoimmune disease or other diseases that require permanent or high-dose immunosuppressive therapy.\n5. Received vaccination with live vaccines within 28 days.\n6. Clinically significant cardiac disease.\n7. Known current malignancy other than inclusion diagnosis.\n8. Has had major surgery within 4 weeks.\n9. Active hepatitis B virus or active hepatitis C.\n10. Known history of HIV.\n11. For R/R CLL arms - Any history of RS or evidence indicating a potential Richter's transformation.\n12. Received venetoclax within 24 months prior to beginning venetoclax ramp-up for this trial and progressed on treatment.\n13. For all RS arms - Diagnosis of Richter's syndrome not of the DLBCL subtype such as Hodgkin's lymphoma, prolymphocytic leukemia.\n14. RS - Lenalidomide Combination Therapy and RS Monotherapy Arms - received more than 2 prior lines of therapy for RS.\n\nNOTE: Other protocol defined Inclusion/Exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Genmab Trial Information",
                    "role": "CONTACT",
                    "phone": "+4570202728",
                    "email": "clinicaltrials@genmab.com"
                }
            ],
            "locations": [
                {
                    "facility": "O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35233",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                },
                {
                    "facility": "City of Hope National Medical Center",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "Cedars-Sinai Medical Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90048",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "David Geffen School of Medicine",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Stanford Cancer Center",
                    "status": "RECRUITING",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                },
                {
                    "facility": "Mount Sinai Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Miami Beach",
                    "state": "Florida",
                    "zip": "33140",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.79065,
                        "lon": -80.13005
                    }
                },
                {
                    "facility": "Memorial Healthcare System",
                    "status": "RECRUITING",
                    "city": "Pembroke Pines",
                    "state": "Florida",
                    "zip": "33024",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.00315,
                        "lon": -80.22394
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University of Michigan Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48190",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Henry Ford Medical Group",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48202",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Hackensack Meridian Hospital",
                    "status": "RECRUITING",
                    "city": "Hackensack",
                    "state": "New Jersey",
                    "zip": "07601",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.88593,
                        "lon": -74.04347
                    }
                },
                {
                    "facility": "Northwell Health Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Lake Success",
                    "state": "New York",
                    "zip": "11043",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.77066,
                        "lon": -73.71763
                    }
                },
                {
                    "facility": "Columbia University Hervert Irving Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "James Cancer Hospital",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "University of Pennsylvania School of medicine",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "The University of Texas Southwestern Medical Centre",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "The University of Texas MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Fred Hutchinson Cancer Research Center",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "St. George Hospital",
                    "status": "RECRUITING",
                    "city": "Kogarah",
                    "state": "New South Wales",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.98333,
                        "lon": 151.11667
                    }
                },
                {
                    "facility": "Barwon Health",
                    "status": "RECRUITING",
                    "city": "Geelong",
                    "state": "Victoria",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -38.14711,
                        "lon": 144.36069
                    }
                },
                {
                    "facility": "Peter MacCallum Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Melbourne",
                    "state": "Victoria",
                    "zip": "3000",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.814,
                        "lon": 144.96332
                    }
                },
                {
                    "facility": "Alfred Health",
                    "status": "RECRUITING",
                    "city": "Melbourne",
                    "state": "Victoria",
                    "zip": "3004",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.814,
                        "lon": 144.96332
                    }
                },
                {
                    "facility": "AZ Sint-Jan",
                    "status": "RECRUITING",
                    "city": "Bruges",
                    "zip": "8000",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 51.20892,
                        "lon": 3.22424
                    }
                },
                {
                    "facility": "Universitair Ziekenhuis Gent",
                    "status": "RECRUITING",
                    "city": "Gent",
                    "zip": "9000",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 51.05,
                        "lon": 3.71667
                    }
                },
                {
                    "facility": "UZ Leuven",
                    "status": "RECRUITING",
                    "city": "Leuven",
                    "zip": "3000",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 50.87959,
                        "lon": 4.70093
                    }
                },
                {
                    "facility": "Vseobecna Fakultni Nemocnice",
                    "status": "RECRUITING",
                    "city": "Praha",
                    "state": "Nov\u00e9 M\u011bsto",
                    "zip": "128 08",
                    "country": "Czechia",
                    "geoPoint": {
                        "lat": 50.08804,
                        "lon": 14.42076
                    }
                },
                {
                    "facility": "Fakultni nemocnice Hradec Kralove",
                    "status": "RECRUITING",
                    "city": "Hradec Kr\u00e1lov\u00e9",
                    "state": "Nov\u00fd Hradec Kr\u00e1lov\u00e9",
                    "zip": "500 05",
                    "country": "Czechia",
                    "geoPoint": {
                        "lat": 50.20923,
                        "lon": 15.83277
                    }
                },
                {
                    "facility": "Fakultni Nemocnice Ostrava",
                    "status": "RECRUITING",
                    "city": "Ostrava",
                    "state": "Poruba",
                    "country": "Czechia",
                    "geoPoint": {
                        "lat": 49.83465,
                        "lon": 18.28204
                    }
                },
                {
                    "facility": "Fakultni nemocnice Brno",
                    "status": "RECRUITING",
                    "city": "Brno",
                    "zip": "625 00",
                    "country": "Czechia",
                    "geoPoint": {
                        "lat": 49.19522,
                        "lon": 16.60796
                    }
                },
                {
                    "facility": "Fakultni nemocnice Olomouc",
                    "status": "RECRUITING",
                    "city": "Olomouc",
                    "zip": "779 00",
                    "country": "Czechia",
                    "geoPoint": {
                        "lat": 49.59552,
                        "lon": 17.25175
                    }
                },
                {
                    "facility": "Rigshospitalet",
                    "status": "RECRUITING",
                    "city": "K\u00f8benhavn",
                    "state": "Hovedstaden",
                    "zip": "2100",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.67594,
                        "lon": 12.56553
                    }
                },
                {
                    "facility": "Aalborg University Hospital",
                    "status": "RECRUITING",
                    "city": "Aalborg",
                    "zip": "9100",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 57.048,
                        "lon": 9.9187
                    }
                },
                {
                    "facility": "Odense University Hospital",
                    "status": "RECRUITING",
                    "city": "Odense",
                    "zip": "5000",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.39594,
                        "lon": 10.38831
                    }
                },
                {
                    "facility": "Roskilde Sygehus",
                    "status": "RECRUITING",
                    "city": "Roskilde",
                    "zip": "4000",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.64152,
                        "lon": 12.08035
                    }
                },
                {
                    "facility": "Vejle Sygehus",
                    "status": "RECRUITING",
                    "city": "Vejle",
                    "zip": "7100",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.70927,
                        "lon": 9.5357
                    }
                },
                {
                    "facility": "\u00c5rhus University Hospital",
                    "status": "RECRUITING",
                    "city": "\u00c5rhus",
                    "zip": "8000",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 56.15674,
                        "lon": 10.21076
                    }
                },
                {
                    "facility": "CHU de Montpellier H\u00f4pital Saint Eloi",
                    "status": "RECRUITING",
                    "city": "Montpellier",
                    "state": "Cedex 5",
                    "zip": "34090",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.61092,
                        "lon": 3.87723
                    }
                },
                {
                    "facility": "CHU H\u00f4pital Haut-L\u00e9v\u00eaque Bordeaux",
                    "status": "RECRUITING",
                    "city": "Pessac",
                    "state": "Gironde",
                    "zip": "33404",
                    "country": "France",
                    "geoPoint": {
                        "lat": 44.81011,
                        "lon": -0.64129
                    }
                },
                {
                    "facility": "CHU H\u00f4pital de Brabois Nancy",
                    "status": "RECRUITING",
                    "city": "Vand\u0153uvre-l\u00e8s-Nancy",
                    "state": "Meurthe Et Moselle",
                    "zip": "54500",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.65,
                        "lon": 6.18333
                    }
                },
                {
                    "facility": "H\u00f4pital Priv\u00e9 du Confluent",
                    "status": "RECRUITING",
                    "city": "Nantes",
                    "state": "Pays De La Loire",
                    "zip": "44000",
                    "country": "France",
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "CHU Clermont Ferrand",
                    "status": "RECRUITING",
                    "city": "Clermont Ferrand cedex",
                    "state": "Puy De Dome",
                    "zip": "63000",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.77966,
                        "lon": 3.08628
                    }
                },
                {
                    "facility": "H\u00f4pital Saint-Louis",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "zip": "75010",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "H\u00f4pital Universitaire Piti\u00e9-Salp\u00eatri\u00e8re",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "zip": "75013",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Universitaetsklinikum Schleswig-Holstein- Karl-Lennart-Krebscentrum",
                    "status": "RECRUITING",
                    "city": "Kiel",
                    "zip": "24105",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 54.32133,
                        "lon": 10.13489
                    }
                },
                {
                    "facility": "Universitaetsklinikum Koeln",
                    "status": "RECRUITING",
                    "city": "Koeln",
                    "zip": "50937",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.93333,
                        "lon": 6.95
                    }
                },
                {
                    "facility": "Bnai Zion Medical Center",
                    "status": "RECRUITING",
                    "city": "Haifa",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.81841,
                        "lon": 34.9885
                    }
                },
                {
                    "facility": "Hadassah University Hospital - Ein Kerem",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Rabin Medical Center-Beilinson Campus",
                    "status": "RECRUITING",
                    "city": "Petah Tikva",
                    "zip": "4941492",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.08707,
                        "lon": 34.88747
                    }
                },
                {
                    "facility": "Chaim Sheba Medical Center",
                    "status": "RECRUITING",
                    "city": "Ramat Gan",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.08227,
                        "lon": 34.81065
                    }
                },
                {
                    "facility": "Tel Aviv Sourasky Medical Center",
                    "status": "RECRUITING",
                    "city": "Tel Aviv-Yafo",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.08088,
                        "lon": 34.78057
                    }
                },
                {
                    "facility": "IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST",
                    "status": "RECRUITING",
                    "city": "Meldola",
                    "state": "Forli - Cesena",
                    "zip": "47014",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.12775,
                        "lon": 12.0626
                    }
                },
                {
                    "facility": "IRCCS Policlinico Universitario Agostino Gemelli",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "state": "Lazio",
                    "zip": "00136",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "AOU Policlinico Sant'Orsola Malpighi IRCCS",
                    "status": "RECRUITING",
                    "city": "Bologna",
                    "zip": "00161",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.49381,
                        "lon": 11.33875
                    }
                },
                {
                    "facility": "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili)",
                    "status": "RECRUITING",
                    "city": "Brescia",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.53558,
                        "lon": 10.21472
                    }
                },
                {
                    "facility": "Ospedale San Raffaele",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "zip": "20132",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Ospedale Maggiore di Novara",
                    "status": "RECRUITING",
                    "city": "Novara",
                    "zip": "28100",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.44694,
                        "lon": 8.62118
                    }
                },
                {
                    "facility": "AOU Policlinico Umberto I",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "zip": "00161",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "zip": "00168",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Maastricht University Medical Center",
                    "status": "RECRUITING",
                    "city": "Maastricht",
                    "state": "Limburg",
                    "zip": "6229 HX",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 50.84833,
                        "lon": 5.68889
                    }
                },
                {
                    "facility": "Albert Schweitzer Ziekenhuis, Dordwijk",
                    "status": "RECRUITING",
                    "city": "Dordrecht",
                    "state": "South Holland",
                    "zip": "3318 AT",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 51.81,
                        "lon": 4.67361
                    }
                },
                {
                    "facility": "Amsterdam UMC",
                    "status": "RECRUITING",
                    "city": "Amsterdam",
                    "zip": "1105 AZ",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 52.37403,
                        "lon": 4.88969
                    }
                },
                {
                    "facility": "Universitair Medisch Centrum Groningen",
                    "status": "RECRUITING",
                    "city": "Groningen",
                    "zip": "9713 GZ",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 53.21917,
                        "lon": 6.56667
                    }
                },
                {
                    "facility": "Universitair Medisch Centrum Utrecht",
                    "status": "RECRUITING",
                    "city": "Utrecht",
                    "zip": "3584 CX",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 52.09083,
                        "lon": 5.12222
                    }
                },
                {
                    "facility": "ICO Badalona - Hospital Universitario Germans Trias Pujol",
                    "status": "RECRUITING",
                    "city": "Badalona",
                    "state": "Barcelona",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.45004,
                        "lon": 2.24741
                    }
                },
                {
                    "facility": "AOC Arcispedale Saint'Anna",
                    "status": "RECRUITING",
                    "city": "Coa\u00f1a",
                    "state": "Ferarra",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 43.51392,
                        "lon": -6.75527
                    }
                },
                {
                    "facility": "Hospital Clinico Universitario de Valencia",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "state": "Val\u00e8ncia",
                    "zip": "46010",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Hospital Clinic de Barcelona",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08036",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital de la Santa Creu i Sant Pau",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Universitario Ram\u00f3n y Cajal",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28034",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario Fundacion Jim\u00e9nez D\u00edaz",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28040",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario Virgen Macarena",
                    "status": "RECRUITING",
                    "city": "Sevilla",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 37.38283,
                        "lon": -5.97317
                    }
                },
                {
                    "facility": "Royal Cornwall Hospital",
                    "status": "WITHDRAWN",
                    "city": "Truro",
                    "state": "Cornwall",
                    "zip": "TR1 3LJ",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 50.26526,
                        "lon": -5.05436
                    }
                },
                {
                    "facility": "Nottingham University Hospitals City Campus",
                    "status": "RECRUITING",
                    "city": "Nottingham",
                    "state": "Nottinghamshire",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 52.9536,
                        "lon": -1.15047
                    }
                },
                {
                    "facility": "St. James s University Hospital",
                    "status": "RECRUITING",
                    "city": "Leeds",
                    "state": "West Yorkshire",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.79648,
                        "lon": -1.54785
                    }
                },
                {
                    "facility": "Barts Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "EC1A 7BE",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007938",
                    "term": "Leukemia"
                },
                {
                    "id": "D000007945",
                    "term": "Leukemia, Lymphoid"
                },
                {
                    "id": "D000015451",
                    "term": "Leukemia, Lymphocytic, Chronic, B-Cell"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000015448",
                    "term": "Leukemia, B-Cell"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M18116",
                    "name": "Leukemia, Lymphocytic, Chronic, B-Cell",
                    "asFound": "Chronic Lymphocytic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "asFound": "Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10951",
                    "name": "Leukemia, Lymphoid",
                    "asFound": "Lymphocytic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18115",
                    "name": "Leukemia, B-Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T1308",
                    "name": "Chronic Lymphocytic Leukemia",
                    "asFound": "Chronic Lymphocytic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T5018",
                    "name": "Richter Syndrome",
                    "asFound": "Richter Syndrome",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011241",
                    "term": "Prednisone"
                },
                {
                    "id": "D000003520",
                    "term": "Cyclophosphamide"
                },
                {
                    "id": "D000069283",
                    "term": "Rituximab"
                },
                {
                    "id": "D000004317",
                    "term": "Doxorubicin"
                },
                {
                    "id": "D000014750",
                    "term": "Vincristine"
                },
                {
                    "id": "D000077269",
                    "term": "Lenalidomide"
                },
                {
                    "id": "C000579720",
                    "term": "Venetoclax"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000019653",
                    "term": "Myeloablative Agonists"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000903",
                    "term": "Antibiotics, Antineoplastic"
                },
                {
                    "id": "D000059005",
                    "term": "Topoisomerase II Inhibitors"
                },
                {
                    "id": "D000059003",
                    "term": "Topoisomerase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000018931",
                    "term": "Antineoplastic Agents, Hormonal"
                },
                {
                    "id": "D000000972",
                    "term": "Antineoplastic Agents, Phytogenic"
                },
                {
                    "id": "D000050257",
                    "term": "Tubulin Modulators"
                },
                {
                    "id": "D000050256",
                    "term": "Antimitotic Agents"
                },
                {
                    "id": "D000050258",
                    "term": "Mitosis Modulators"
                },
                {
                    "id": "D000020533",
                    "term": "Angiogenesis Inhibitors"
                },
                {
                    "id": "D000043924",
                    "term": "Angiogenesis Modulating Agents"
                },
                {
                    "id": "D000006133",
                    "term": "Growth Substances"
                },
                {
                    "id": "D000006131",
                    "term": "Growth Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6727",
                    "name": "Cyclophosphamide",
                    "asFound": "Effect of",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7492",
                    "name": "Doxorubicin",
                    "asFound": "Cognitive",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17495",
                    "name": "Vincristine",
                    "asFound": "Phase I",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M14121",
                    "name": "Prednisone",
                    "asFound": "Prospective",
                    "relevance": "HIGH"
                },
                {
                    "id": "M249656",
                    "name": "Venetoclax",
                    "asFound": "0.1",
                    "relevance": "HIGH"
                },
                {
                    "id": "M373",
                    "name": "Rituximab",
                    "asFound": "Infusion",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1725",
                    "name": "Lenalidomide",
                    "asFound": "Respiratory",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20194",
                    "name": "Antibodies, Bispecific",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M227339",
                    "name": "Liposomal doxorubicin",
                    "relevance": "LOW"
                },
                {
                    "id": "M19201",
                    "name": "Muromonab-CD3",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4224",
                    "name": "Antibiotics, Antitubercular",
                    "relevance": "LOW"
                },
                {
                    "id": "M29348",
                    "name": "Topoisomerase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20966",
                    "name": "Antineoplastic Agents, Hormonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M26197",
                    "name": "Tubulin Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M26196",
                    "name": "Antimitotic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M22318",
                    "name": "Angiogenesis Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M9231",
                    "name": "Growth Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                }
            ]
        }
    },
    "hasResults": false
}